Skip to main content

Ventricular Tachycardia clinical trials at UCSD

2 in progress, 1 open to eligible people

Showing trials for
  • FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

    open to eligible people ages 18 years and up

    This clinical investigation is intended to demonstrate the safety and effectiveness of ventricular ablation therapy using the FlexAbility Sensor Enabled Ablation Catheter in patients with drug-refractory monomorphic ventricular tachycardia in whom ventricular tachycardia recurs despite antiarrhythmic drug therapy or when antiarrhythmic drugs are not tolerated or desired.

    San Diego, California and other locations

  • Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

    Sorry, not currently recruiting here

    Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted within Medtronic's Product Surveillance Registry platform (NCT01524276).

    Chula Vista, California and other locations

Last updated: